首页> 外文期刊>Transplantation Proceedings >Recipient immature dendritic cells do not prolong allograft survival.
【24h】

Recipient immature dendritic cells do not prolong allograft survival.

机译:接受者未成熟树突状细胞不能延长同种异体移植物的存活。

获取原文
获取原文并翻译 | 示例
           

摘要

Experimental studies on allogeneic transplantation have shown that recipient dendritic cells (DC) play a role in peripheral tolerance as well as in rejection of allografts. It is not known whether DCs exert their tolerogenic function in the graft or in recipient lymphoid tissue. To answer this question we created a chimeric heart model deprived of its own DCs and repopulated with recipient DCs. The rationale for this model was to observe whether recipient mature and immature DCs located in the graft attenuate recruitment and stimulation of recipient lymphocytes, subsequently prolonging graft survival. Vascularized bone marrow transplants from the prospective recipient to the lethally irradiated heart donor, which function for a period of 14 days, were used to replace donor DCs with prospective recipient either mature or immature DCs. Replacement of the donor heart with either of these cells did not prolong graft survival. The intragraft microchimerism did not mitigate the allogeneic rejection reaction.
机译:对同种异体移植的实验研究表明,受体树突状细胞(DC)在外周耐受以及同种异体移植的排斥中发挥作用。尚不清楚DC是否在移植物或受体淋巴组织中发挥其致耐受功能。为了回答这个问题,我们创建了一个嵌合心脏模型,该模型被剥夺了自己的DC,并重新填充了接受者DC。此模型的基本原理是观察位于移植物中的受体成熟和未成熟的DC是否会减弱受体淋巴细胞的募集和刺激,从而延长移植物的存活时间。从预期接受者到接受致命照射的心脏供体的血管化骨髓移植(功能持续14天)被成熟或未成熟的预期接受者替换为供体DC。用这两种细胞中的任一种代替供体心脏都不能延长移植物的存活。移植物内微嵌合不能减轻同种异体排斥反应。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号